| P2093 | author name string | Shuyan Li | |
| | Zhi Liang | |
| | Haixia Lin | |
| | Rongzhan Fu | |
| | Licheng Xu | |
| P2860 | cites work | In vitro activities of furoquinoline and acridone alkaloids against Plasmodium falciparum | Q24679711 |
| | Analysis of Relative Gene Expression Data Using Real-Time Quantitative PCR and the 2−ΔΔCT Method | Q25938999 |
| | Cancer drug resistance: an evolving paradigm | Q29616694 |
| | The contribution of cytotoxic chemotherapy to 5-year survival in adult malignancies | Q33984198 |
| | Global patterns of cancer incidence and mortality rates and trends | Q34127168 |
| | Discovering natural product modulators to overcome multidrug resistance in cancer chemotherapy | Q35915497 |
| | Drug rechallenge and treatment beyond progression--implications for drug resistance. | Q35967416 |
| | Multidrug resistance: retrospect and prospects in anti-cancer drug treatment. | Q36536479 |
| | Natural and synthetic acridines/acridones as antitumor agents: their biological activities and methods of synthesis. | Q37878209 |
| | Acridine and acridinones: old and new structures with antimalarial activity | Q37889659 |
| | Metastatic behavior of breast cancer subtypes | Q38416421 |
| | Physicochemical interaction of antitumor acridinone derivatives with DNA in view of QSAR studies. | Q38610793 |
| | Cytotoxicity studies of some novel fluoro acridone derivatives against sensitive and resistant cancer cell lines and their mechanistic studies | Q39544255 |
| | Synthesis of new acridone derivatives, inhibitors of NS3 helicase, which efficiently and specifically inhibit subgenomic HCV replication | Q39722943 |
| | Design, synthesis and evaluation of 4,5-di-substituted acridone ligands with high G-quadruplex affinity and selectivity, together with low toxicity to normal cells | Q39819318 |
| | Potential anti-allergic acridone alkaloids from the roots of Atalantia monophylla | Q39935681 |
| | Anti-herpesvirus activity of citrusinine-I, a new acridone alkaloid, and related compounds | Q42189056 |
| | Breast cancer subtype approximated by estrogen receptor, progesterone receptor, and HER-2 is associated with local and distant recurrence after breast-conserving therapy. | Q42434873 |
| | Unique features of breast cancer in Asian women--breast cancer in Taiwan as an example. | Q42465227 |
| | Breast cancer molecular subtypes respond differently to preoperative chemotherapy | Q42482998 |
| | Development of highly predictive 3D-QSAR CoMSIA models for anthraquinone and acridone derivatives as telomerase inhibitors targeting G-quadruplex DNA telomere | Q42944015 |
| | Synthesis and antileishmanial activity of (1,3-benzothiazol-2-yl) amino-9-(10H)-acridinone derivatives | Q44994583 |
| | Comparison of estrogen receptor, progesterone receptor and Her-2 status in breast cancer pre- and post-neoadjuvant chemotherapy | Q46555637 |
| | Breast cancer as a global health concern. | Q50560105 |
| | Synthesis of the acridone alkaloids, glyfoline and congeners. Structure-activity relationship studies of cytotoxic acridones | Q68215828 |
| P4510 | describes a project that uses | ImageQuant | Q112270642 |
| P433 | issue | 2 | |
| P304 | page(s) | 2651-2654 | |
| P577 | publication date | 2017-12-11 | |
| P1433 | published in | Oncology Letters | Q20640514 |
| P1476 | title | Acridone suppresses the proliferation of human breast cancer cells in vitro via ATP-binding cassette subfamily G member 2. | |
| P478 | volume | 15 | |